Introduction
The S100 protein family includes >20 low-molecularweight intracellular proteins containing an EF-hand motif and showing calcium-binding properties (Donato, 2001) . A recent study showed that S100 proteins play important roles in cancer malignancy and metastasis (Donato, 2003) . Most S100 proteins perform several intracellular and extracellular functions. Intracellular functions of S100 proteins include regulation of calcium homeostasis, cell cycle, cell growth, and cell migration and regulation and phosphorylation of transcriptional factors. Extracellular function of S100 proteins is activated by the binding of tumor necrosis α (TNF-a), interleukin-1 (IL-1), IL-6, chemokines, matrix metalloproteinases (MMPs), angiogenesis factors, and antiapoptotic proteins as cytokines to cell surface receptors (Chen et al., 2014) . Three receptor types recognize S100 proteins, namely the receptor for advanced glycation end products (RAGE), Toll-like receptors (TLRs), and the extracellular MMP inducer (EMMPRIN) (Hiratsuka et al., 2008) . RAGE is a multiligand receptor belonging to the immunoglobulin superfamily that is involved in inflammation, diabetes, atherosclerosis, nephropathy, neurodegeneration, and cancer (Sorci et al., 2004) . S100A9, a member of the S100 protein family, interacts with RAGE, TLRs, and EMMPRIN (Sakaguchi et al., 2011) . EMMPRIN is a well-known cell surface molecule associated with cancer cell malignancy (Gabison et al., 2005) . The binding of S100A9 to EMMPRIN provides new insight into the molecular mechanism underlying S100A9-EMMPRINmediated inflammation and melanoma cancer cell metastasis (Sakaguchi et al., 2011) . EMMPRIN is also involved in fetal development, retinal function, nervous system development, and plaque formation in Alzheimer disease (Iacono et al., 2007) . S100A9 is mainly expressed in myeloid cells and performs a key role in these cells under inflammatory conditions (Urban et al., 2009) . In humans, serum levels of S100A9 increase during several disease conditions, including acute inflammatory lesions, cystic fibrosis, rheumatoid arthritis, and amyloids in the aging prostate gland (Vogl et al., 2012) . Melanoma is the most aggressive type of skin cancer, involving a type of skin cells called melanocytes (Nylund et al., 2012) . Mutations, chemical agents, and aberrant epigenetic alterations are among the several risk factors of cancers (Lee et al., 2012) . DNA methylation, histone modification, nucleosome remodeling, and RNA-mediated targeting regulate many biological processes that are fundamental to the pathogenesis of cancer (Dawson et al., 2012) . Global hypomethylation is commonly observed in malignant cells (Azad et al., 2013) . The best-studied epigenetic alterations in cancer cells are methylation changes occurring within CpG islands, which are present in ∼70% of all mammalian promoters. CpG island methylation plays an important role in transcriptional regulation and is commonly altered during malignant transformation (Baylin et al., 2011) . Aberrant DNA methylation is one of the epigenetic alterations occurring in the promoters of tumor suppressor genes and oncogenes (Yang et al., 2011) . DNA methylation is a heritable epigenetic modification that occurs mostly at CpG dinucleotides, except CpGs in CpG islands (Weber et al., 2005) . DNA methylation is induced by DNA-cytosine methyltransferase-1. CpG islands are generally unmethylated in normal adult tissues, except CpG islands in transcriptionally silent genes in the inactive X-chromosome and in imprinted genes (Ducasse et al., 2006) . Tight junctions (TJs) are major structures of endothelial cells in brain capillary walls that regulate the diffusion of ions, nutrients, and cells into the brain and cerebrospinal fluid (Hirase et al., 2001) . A family of proteins called claudins are the most important components of TJs. Twenty-four claudins have been identified to date. Genes encoding different claudins, namely CLDN2, CLDN3, CLDN4, CLDN11CL, CLDN12, CLDN14, and CLDN15, are located on chromosome 7. OCLN, a TJ gene located on chromosome 5 (cytogenetic band 5q13.2), encodes occludin, which plays an important role in the formation and regulation of TJs (Gabison et al., 2005; Rachow et al., 2013) . Occludin induces adhesion when expressed in cells lacking TJs (Yashin et al., 2013) . Occludin contains a long cytoplasmic domain rich in serine, threonine, and tyrosine, and phosphorylation levels of serine and threonine residues of occludin are strongly correlated with TJ formation. Occludin directly associates with cytoplasmic scaffolding proteins such as zona occludens-1, a submembrane component of TJs, thus directly associating with the actin cytoskeleton (Osanai et al., 2006) . Disruption of the TJ structure is associated with cancer development, invasion, and metastasis to distant sites (Tobioka et al., 2006) . Conversely, overexpression of TJ-related proteins such as claudin-1 and claudin-4 in cancer cells induces apoptosis and suppresses the metastatic potency of these cells (Osanai et al., 2006) . At present, no effective treatment is available for treating melanoma, and early diagnosis and chemotherapy are the only options for treating patients with this cancer (Sgambato et al., 2010) . The present study investigated OCLN expression level in melanoma cell line A-375 treated with and without calprotectin subunit S100A9. Moreover, this study assessed the methylation status of the OCLN promoter in A-375 melanoma cells treated with and without recombinant S100A9.
Methods and materials

Materials
Isopropyl β-d-1-thiogalactopyranoside (IPTG) (1 mM), Ni-NTA resin, Tris, acrylamide, bacterial and media (LB broth) were purchased from Sigma-Aldrich (Germany). Ampicillin was purchased from Roche, and sodium chloride (NaCl), sodium dihydrogen phosphate (NaH 2 PO 4 ), calcium chloride (CaCl 2 ), and imidazole were obtained from AppliChem. Competent Escherichia coli strain BL21 (DE3) and the N-terminal S100A9 coding sequence were provided by Novagen. Human melanoma cell line A-375 (NCBI No. Index: C-136) was obtained from the Pasteur Institute of Iran. Chemicals, culture media, and related compounds were purchased from GIBCO Co. Cell viability was measured by performing the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. RNA was extracted using a GeneAll kit , and cDNA was synthesized using a first-strand cDNA synthesis kit (Thermo Scientific). Real-time PCR was performed using SYBR Green master mix (TAKARA BIO INC., Cat No. RR820Q) and the ABI StepOne qRT-PCR system. 2.2. Methods 2.2.1. Transformation, expression, and purification of S100A9 protein After transformation of the pET15b vector including the his-tagged S100A9 gene to the Escherichia coli BL21 (DE3) host cells, the expression of S100A9 protein was induced by 1 mM IPTG. The expressed S100A9 was purified by performing Ni-NTA affinity chromatography and verified as reported in our previous study (Asghari et al., 2016) . Purified his-tagged r-S100A9 was observed with the SDS-PAGE analysis technique.
Cell culture and cell viability measurement
A-375 melanoma cells were cultured in high-glucose DMEM supplemented with 15% fetal bovine serum, 100 U/mL penicillin, and 100 g/mL streptomycin at 37 °C in a humidified CO 2 incubator with an atmosphere of 5% CO 2 and 95% air. Cell cultures were examined regularly. The MTT assay was performed using cells in three 96-well plates incubated for 24, 48, and 72 h. The cells were cultured overnight at a density of 8000 cells/well in culture medium to attach the plate. Next, the medium was replaced with a medium containing different concentrations (2.5, 5, and 7.5 µM) of S100A9, and the cells were incubated for 24, 48, and 72 h. 2.3. RNA extraction and first-strand cDNA synthesis Total RNA was extracted from 1 × 10 5 A-375 cells treated with S100A9 by using the GeneAll kit , and the quality of the extracted RNA was determined by performing gel electrophoresis. An equal amount of RNA (100 ng) from each sample was added to 25 µL of reaction mixture, and cDNA was synthesized using a first-strand cDNA synthesis kit and M-MuLV reverse transcriptase (Thermo Scientific). The quality of the synthesized cDNA was assessed by performing NanoDrop spectroscopy and gel electrophoresis.
Real-time PCR
To examine the effects of S100A9 on OCLN expression, we treated A-375 cells with 3 concentrations (2.5, 5, and 7.5 µM) of S100A9 for 24, 48, and 72 h. Real-time PCR was performed after extracting RNA from the treated A-375 cells and synthesizing first-strand cDNA. Primers for qRT-PCR were obtained from Tag Copenhagen A/S (Denmark). Sequences of primers for the human OCLN cDNA are as follows: 5′-GACTTCAGGCAGCCTCGTTAC-3′ (forward) and 5′-GCCAGTTGTGTAGTCTGTCTCA-3′ (reverse). Tm of the forward primer was 56.3 °C and that of the reverse primer was 54.8 °C. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as an internal control. Primer sequences for GAPDH are as follows: 5′-CAATGACCCCTTCATTGACC-3′ (forward) and 5′-AATCCCATCACCATCTTCCA-3′ (reverse). The PCR protocol was as follows: initial denaturation at 95 °C for 5 min, followed by 40 cycles of denaturation at 95 °C for 20 s and annealing and extension at 60 °C for 60 s. Relative gene expression was calculated using the comparative CT method (Schmittgen et al., 2008) . GAPDH expression was used to calculate the delta CT value and to determine the fold change compared with gene expression in control cells (untreated A-375 melanoma cells). Gene expression was determined using the ABI StepOne Real-Time PCR system and SYBR Green master mix and was analyzed using the Pfaffl method and GraphPad Prism v6.07 software. All trials were done triplicate. 2.5. DNA extraction and methylation-specific PCR A-375 cells were harvested at 24, 48, and 72 h after S100A9 treatment. Genomic DNA was extracted using the MiniBEST Universal Genomic DNA Extraction Kit, and DNA concentration was assessed using a NanoDrop ND-1000 spectrophotometer. The extracted DNA was modified using sodium bisulfite with the EpiTect Bisulfite Kit (QIAGEN, Germany), according to the manufacturer's instructions. Primers for methylation-specific PCR (MSP-PCR) were as follows: (1) 5′-AGTATCGAACGTATTTCGGGG-3′ and 5′-GCGCTCACCTAACGAACGCA-3′ for amplifying methylated alleles and
5′-AGTTTTAGGTGAATTGGTTATTGAG-3′ and 5′-ACAACCTTAATCTACCAAACTCAAA-3′ for amplifying unmethylated alleles. MSP-PCR of the sodium bisulfite-modified DNA was performed to determine the methylation status of CpG islands in the OCLN promoter. MSP-PCR was performed using the following thermal cycling conditions: initial denaturation at 95 °C for 15 min, followed by 40 cycles of denaturation at 95 °C for 20 s and annealing and extension at 58 °C for 45 s.
Statistical analysis
Statistical analysis was performed using the Pfaffl method and GraphPad Prism v. 6.07. Data are presented as mean ± SD. P < 0.05 was considered significant.
Results
Recombinant S100A9 expression and purification
Expressed recombinant S100A9 had an apparent molecular weight of approximately 14 kDa compared with the logarithmic molecular weights of standard marker proteins (Figure 1) . Results of the protein assay indicated that the expression yield of recombinant S100A9 was equal to 0.07 mg/mL.
Proliferation assay after cells' treatment with S100A9
We treated A-375 human melanoma cells with various concentrations (2.5, 5, 7.5, and 10 µM) of S100A9 for 24, 48, and 72 h and assessed their viability by MTT assay. The IC 50 values of S100A9 after treatment for 24, 48, and 72 h were 12.5, 6.9, and 5.3 µM, respectively.
Expression of OCLN
The expression of OCLN in S100A9-treated A-375 cells with three concentrations (2.5, 5, and 7.5 µM) for 24, 48, and 72 h was compared with that in untreated control A-375 cells and the internal control, GAPDH. In Figure 2 , the melting curves obtained for internal control (GAPDH) and the OCLN gene are 89.3 °C and 82.73 °C, respectively. The expression ratio after standardization (fold change) of the OCLN gene is illustrated in Figure 3 . The expression gene of samples (treated) was gradually decreased relative to the control (without treatment) in a time-and concentrationdependent manner.
Methylation status of the OCLN promoter
We also assessed the methylation status of the OCLN promoter. A-375 melanoma cells were treated with different concentrations of S100A9 for different times. Next, the cells were harvested, and their DNA was extracted. As illustrated in Figures 4 and 5 the MSP-PCR was performed after treating the extracted DNA with bisulfate. Results of MSP-PCR showed that the OCLN promoter was semimethylated.
Discussion
Results of the present study showed that the viability of A-375 melanoma cells decreased after treatment with recombinant S100A9, with IC 50 values of 12.5, 6.9, and 5.3 µM after treatment for 24, 48, and 72 h, respectively. Previously, we assessed calprotectin subunits S100A8 and S100A9 and their physicochemical properties such as interaction with tyrosinase (Nemati Niko et al., 2017) . S100A9 inhibits tyrosinase, which is overexpressed in melanomas. This inhibitory effect of S100A9 on tyrosinase is consistent with the inhibitory effects of other aromatic compounds on tyrosinase and proliferation of A-375 melanoma cells (Gheibi et al., 2015) . There are many investigations that emphasize S100A8/A9 subunits as molecular targets and important biological markers of cancer and inflammatory studies. The S100A8 and S100A9 subunits are targets of protumorigenic and proapoptotic signaling pathways and activate many downstream effector genes that promote tumor progression (Ang et al., 2010) . Figure 1 . SDS-PAGE of purified S100A9 subunit of calprotectin (S100A9). S100A9 sequences were inserted in the vector (pET15b) and expressed in Escherichia coli BL21 (DE3), and they were purified using Ni-NTA affinity chromatography and verified as the right protein. Lanes 1, 2, and 3 represent S100A9 before purification and lanes 4, 5, and 6 after purification. Temperature melting values for PCR products of GAPDH (internal control) and PCR products of occludin were 89.3 °C and 82.88 °C, respectively. For obtaining the standard curve, several samples were mixed together and serial dilution was conducted (0.01, 0.1, 1, 10, and 100). The standard curve was drawn for both the sample and control. The melting curve showed that there existed no none-specific product, contamination, and primer dimer.
Expression of S100A8 and S100A9 is downregulated in some tumors, including squamous cell carcinomas of the head and neck and of the esophagus (Ghavami et al., 2008) . Previous studies have shown that S100A8 and S100A9 exert dose-dependent effects on cell proliferation.
Low concentrations of S100A8 and S100A9 promote proliferation, migration, and angiogenesis, whereas high concentrations of S100A9 exert a proapoptotic effect on vascular endothelial cells (Li et al., 2012) . Stable expression of calprotectin subunits in HeLa-KB cells suppresses carcinoma growth in vivo and in vitro by restoring the G2/M cell cycle checkpoint (Chen et al., 2014) . Moreover, silencing of endogenous S100A8 and S100A9 expression in HNSCC cells increases in vitro tumor growth and transformation (Rezaei-Tavirani et al., 2008) . Knockdown of S100A9 with siRNA inhibits metastasis and migration in gastric cancer cells (Turovskaya et al., 2008) . In line with the above studies, melanoma cell line (A-375) treatment with recombinant S100A9 in this study inhibited the cell proliferation in a time-and concentration-dependent manner. As mentioned in Section 1, S100A9's external impact on cancer cell line should be implemented by its binding to three types of receptors, RAGE, TLRs, and EMMPRIN. The interaction between RAGE and various ligands such as HMGB1 (high mobility group box 1) protein activated the nuclear factor kappa-lightchain enhancer of activated B-cells, promoting cellular proliferation, invasion, and metastasis (Turovskaya et al., 2009; Nguyen et al., 2017) . Ichikawa et al. (2011) showed that S100A8 and S100A9 interact with RAGE to activate MAPK and NF-kB signaling pathways. NF-kB is a critical link between inflammation and cancer (Ichikawa et al., 2011) . Moreover, S100A9 is a novel NF-kB target protein in hepatic carcinoma cells during inflammationmediated liver carcinogenesis (Németh et al., 2009 ). An important aspect of brain metastasis is the migration of cancer cells through the blood-brain barrier. TJs between cells play an essential role in keeping cells bound together. Occludin is an important protein involved in the generation of TJs. Any disruption in the TJ or occludin structure (through mutation, methylation, decreased gene expression, etc.) disrupts the cells and probably their migration (Simona et al., 2014) . The results of qRT-PCR in Figure 3 show that OCLN gene expression decreased in A-375 melanoma cells after treatment with different concentrations of S100A9. According to these results, the MTT assay confirmed the qRT-PCR data. It was shown that treatment of the melanoma cell line with S100A9 was time-and dose-dependent such that increasing the time and concentration of incubation decreased the occludin expression. As mentioned in Section 1, occludin has a pivotal role in the stabilization of the cellular connection and inhibition of apoptosis in natural cells (Beeman et al., 2012) . Here, the expression of occludin in the A-375 melanoma cell line decreased under treatment with S100A9, and this may lead to the induction of apoptosis and reduced cell viability. Meanwhile, previous studies showed that decrease of occludin expression resulted in induction of metastasis in a melanoma cell line (Tracey et al., 2010) . Thus, occludin, as an important component of TJ proteins, may be used as a target for therapeutic interventions. It should also be noted that method used in this study for the surveying of promoter methylation status was qualitative. In Figures 4 and 5 , the MSP-PCR method shows that the OCLN gene promoter in the A-375 cell line was semimethylated. This method only indicates the presence or absence of methylation. Therefore, the modification of the methylation pattern before and after treatment could not be in conflict with the results of MTT and qRT-PCR.
In conclusion, S100A9 treatment of the A-375 melanoma cell line reduced the cell proliferation and OCLN gene expression. The roles of S100A9 need more investigation to clarify its mechanistic effects on anticancer and metastatic processes and in particular it could be an important link and a good crosstalk factor between inflammation and cancer. 
